Biotech Industry News
A collection of Biotech latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
A biotech stock for investors scared to invest in the risky industry
Citigroup thinks investors should consider Ligand Pharmaceuticals for a more conservative bet on the biotech industry. The bank initiated the biotech stock at a buy rating and price target of $270, implying upside of 46% from Ligand's Monday…
Idorsia's treatment for insomnia disorder wins the inaugural Prix Galien Bridges Award in the 'Best Biotechnology & Pharmaceutical Product' category
Idorsia's dual orexin receptor antagonist, the first and only drug of its kind approved in Europe for the treatment of insomnia disorder, has been awarded the inaugural Prix Galien Bridges Award in the category of “Best Biotechnology &…
A little-known biotech stock more than doubled this week. Why Wells Fargo sees further upside
Wave Life Sciences offers an exciting new obesity treatment that can translate to big gains ahead, according to Wells Fargo. The bank reiterated the Singapore-based biotech name as overweight and hiked its price target to $29 per share from $16.
Seoul attracts $50m biotech investment from China's venture capital
Seoul has secured a $50 million investment commitment through a memorandum of understanding with a major Chinese health care venture capital firm, as the city moves to deepen cross-border cooperation in finance, biotechnology and robotics…
Biotech stock soars 40% on JPMorgan's bold call
JPMorgan's bullish rating sends Vor Biopharma shares skyrocketing on promising autoimmune disease treatment Vor Biopharma experienced a remarkable morning on December 9, 2025, as shares of the biotech company surged more than 40% in premarket…
ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive
ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today released findings from two biotech sector surveys. The first survey focused on global biotech trends and is an update of our 2023 survey, while the second survey focused…
Average Boston rent down for first time in years - but still over $3K
Boston's rental market has tipped ever-so-slightly in renters' favor, partially owing to out-of-state migration, a cooling biotech industry, and tighter student visa restrictions, according to a recent Bloomberg report. On the one hand, vacancies…
Promising Biotech Stocks To Keep An Eye On - December 9th
Wave Life Sciences Rockets 70% on Historic RNA Editing Success WAVE Life Sciences, Exicure, argenex, Danaher, Senti Biosciences, Abivax, and Vertex Pharmaceuticals are the seven Biotech stocks to watch today, according to MarketBeat's stock…
Legend Biotech (NASDAQ:LEGN) Trading Down 4.7% - Time to Sell?
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Get Free Report) shares were down 4.7% during mid-day trading on Tuesday. The company traded as low as $24.22 and last traded at $24.8970. Approximately 1,571,366 shares were traded during…
Mounjaro In China: Assessing Market Potential And Risks (NYSE:LLY)
Eli Lilly (LLY) is set to add Mounjaro to China's national reimbursement list, dramatically expanding its reach in the diabetes market. LLY's bull case hinges on securing reimbursement for Mounjaro's obesity and sleep apnea indications, unlocking…
A Trojan horse for artificial amino acids
Researchers from ETH Zurich have modified a bacterial transport system so that it can efficiently introduce large quantities of unnatural amino acids into cells, disguised as a kind of Trojan horse. All organisms manufacture their proteins from the…
Ghanaian president urges private sector to co-invest in Africa's health industrialization
ACCRA, Dec. 9 (Xinhua) -- Ghanaian President John Dramani Mahama on Tuesday urged private sector players to collaborate with African governments in co-investing in the continent's health industrialization to enhance healthcare and service delivery.
Here are key tech provisions the NDAA includes and excludes
Two key AI provisions were left out of the final text of the National Defense Authorization Act (NDAA) after failing to overcome Republican divisions, while a pair of measures restricting investments and contracts with China made it into the…
Big Pharma's Patent Cliff Puts China Front and Center
For pharmaceutical firms, watching the lucrative patents on their top-selling drugs expire has long been part of the business cycle. There's enormous pressure to find ways of covering the shortfall. For the first time, China has something to offer.
Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival
LAS VEGAS, Dec. 9, 2025 /CNW/ -- Avant Technologies, Inc. (OTCQB: AVAI) ('Avant' or the 'Company'), an emerging biotechnology company focused on developing cell-based therapies for diabetes and age-related disorders, today announced a newly…
Receive a Daily briefing on Biotech Industry News
Get Started